Tilray Brands TLRY
NASDAQ TLRY
$4.68 -0.15 (-3.11%)
As of: Aug 20, 2026 · 3:59 PM EDT

Tilray Brands (TLRY) Gains from Investment Securities (2019 - 2025)

Tilray Brands' (TLRY) quarterly Gains from Investment Securities came in at -$15.0 million in Q3 2025, down 1600.0% on a QoQ basis from $1.0 million in Q2 2024.

Tilray Brands (TLRY) Gains from Investment Securities (2019 - 2025) Analysis & Trends

Tilray Brands (TLRY) has 7 years of Gains from Investment Securities data on file, last reported at -$15.0 million in Q3 2025.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to -$15.0 million in Q3 2025, while the trailing twelve-month figure through May 2026 was -$15.0 million (changed N/A YoY) and the FY2026 annual result came in at -$15.0 million, changed N/A from the prior year.
  • Gains from Investment Securities eased to -$15.0 million in Q3 2025, from $1.0 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.0 million in Q2 2024 to a low of -$30.7 million in Q1 2022.
  • A 5-year average of -$6.2 million and a median of $251500.0 in 2022 frame the typical range for Gains from Investment Securities.
  • Annual changes were most pronounced in 2023 — Gains from Investment Securities plunged 5363.98% — and 2024, when it jumped 242.47%.
  • Tracing TLRY's Gains from Investment Securities over 5 years: stood at $845000.0 in 2021, then sank by 75.03% to $211000.0 in 2022, then jumped by 42.18% to $300000.0 in 2023, then soared by 233.33% to $1.0 million in 2024, then sank by 1600.0% to -$15.0 million in 2025.
  • The last three Gains from Investment Securities figures came in at -$15.0 million (Q3 2025), $1.0 million (Q2 2024), and -$6.0 million (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Tilray Brands 523.93 Mn 289.30 Mn 90.52 Mn

Historic Data

Download Data
DateValue
Aug 31, 2025 -15.00 Mn
Aug 31, 2025 -15.00 Mn
May 31, 2024 1.00 Mn
May 31, 2024 1.00 Mn
Feb 29, 2024 -5.98 Mn
Feb 29, 2024 -5.98 Mn
Nov 30, 2023 300,000.00
Nov 30, 2023 300,000.00
Aug 31, 2023 -11.11 Mn
Aug 31, 2023 -11.11 Mn
May 31, 2023 292,000.00
May 31, 2023 292,000.00
Feb 28, 2023 352,000.00
Feb 28, 2023 352,000.00
Aug 31, 2022 211,000.00
Aug 31, 2022 211,000.00
May 31, 2022 -15.59 Mn
May 31, 2022 -15.59 Mn
Feb 28, 2022 -30.75 Mn
Feb 28, 2022 -30.75 Mn